Oxycodone Completed Phase 3 Trials for Moderate-to-severe Chronic Low Back Pain Treatment

IndicationsStatusPurposePhase
CompletedTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT02716857Efficacy and Safety of Egalet-002 in Patients With Moderate-to-Severe Chronic Low Back Pain